←
JelenaBezbradicaLab470 posts
JelenaBezbradicaLab avatar

JelenaBezbradicaLab

@JelenaLab
◷ Joined March 2020▧ 20 Photos and videos
JelenaBezbradicaLab avatar
JelenaBezbradicaLab@JelenaLab·Apr 17

How lytic cell death drives autoantigen release and fuels inflammation? With @lynndustinlab we ask this using a common autoantigen, TRIM21. The autoantigen TRIM21 assembles proinflammatory immune complexes after lytic cell death | Science Immunology science.org/eprint/VEVN4EQK8…

JelenaBezbradicaLab avatar
JelenaBezbradicaLab@JelenaLab·Nov 16

lnkd.in/p/eNZGgEcy join us on Nov 23rd for half day online Cell Death Symposium, registration is still open and details are in the link.

Jonathan Kagan avatar
⟳ JelenaBezbradicaLab retweeted
Jonathan Kagan@jkagan1·Jul 17

A new PAMP, a new innate immunity principle and a new preclinical application. I am so pleased to share our study on STING activation mechanisms in health and disease. Led by the fantastic Stephanie Ragland, follow the summary below for all we learned. cell.com/immunity/fulltext/S…

Clare Bryant (clarebryant@bsky.social) avatar
⟳ JelenaBezbradicaLab retweeted
Clare Bryant (clarebryant@bsky.social)@ClareBryant13·Apr 21

Calling all Inflammazoomers: after brilliant talks from Siddharth Balachandran, Marcus Taylor, Katia Cosentino and Tanita Wein (catch up on the Abcam Hub) this Thurs we have 2 more..... Rachel Lai and Jueqi Chen GMT 15:00+1

Dr Eva Frickel avatar
⟳ JelenaBezbradicaLab retweeted
Dr Eva Frickel@FrickelLab·Mar 4

Hot off the biorxiv press! 🔥 @SamuelLaraR finds GBP5 enhances macrophage glycolysis via glucose uptake, GTPase activity dependent and as being cis-Golgi localised. Bonus finding, GBP5 is important for full M1 macrophage functionality. biorxiv.org/content/10.64898…

JelenaBezbradicaLab avatar
JelenaBezbradicaLab@JelenaLab·20 Oct 2025

Reminder: new #InflammaZoom free Webinar is today at 2 pm BST with James Murphy @pseudokinase from WEHI and Jonathan Maelfait from VIB Ghent. Register via Abcam link below. See you soon!

Abcam@abcam8 Oct 2025

InflammaZoom is back on October 20. Tune in from 2:00 to 3:00 PM BST for a deep dive into innate immunity and inflammasome biology. Hear from James Murphy (WEHI, Melbourne, Australia) and Jonathan Maelfait (VIB-UGent, Ghent, Belgium). Register now: bit.ly/4iXGqjw #InflammaZoom #innateimmunity #inflammasomebiology

Post attachment
JelenaBezbradicaLab avatar
JelenaBezbradicaLab@JelenaLab·17 Oct 2025

Looking forward to hosting James Murphy @pseudokinase and Jonathan Maelfait @InflamResCen as #InflammaZoom speakers on Monday October 20th. Register below via Abcam link for this free Webinar.

Abcam@abcam8 Oct 2025

InflammaZoom is back on October 20. Tune in from 2:00 to 3:00 PM BST for a deep dive into innate immunity and inflammasome biology. Hear from James Murphy (WEHI, Melbourne, Australia) and Jonathan Maelfait (VIB-UGent, Ghent, Belgium). Register now: bit.ly/4iXGqjw #InflammaZoom #innateimmunity #inflammasomebiology

Post attachment
JelenaBezbradicaLab avatar
JelenaBezbradicaLab@JelenaLab·16 Oct 2025

Do not miss this! #inflammazoom is back in October 🎉 with James Murphy from WEHI and Jonathan Maelfait from VIB Ghent we are back with some really 🔥 stories!

Abcam@abcam8 Oct 2025

InflammaZoom is back on October 20. Tune in from 2:00 to 3:00 PM BST for a deep dive into innate immunity and inflammasome biology. Hear from James Murphy (WEHI, Melbourne, Australia) and Jonathan Maelfait (VIB-UGent, Ghent, Belgium). Register now: bit.ly/4iXGqjw #InflammaZoom #innateimmunity #inflammasomebiology

Post attachment
Dave Boucher avatar
⟳ JelenaBezbradicaLab retweeted
Dave Boucher@dave_boucher·3 Aug 2025

New review from our lab. Kudos to PhD student @SebGrant346534. 10 things you wish you knew about inflammatory caspases: a holistic review of their biochemistry, activation, and signalling - Journal of Biological Chemistry jbc.org/article/S0021-9258%2…

Dr Rebecca Coll avatar
⟳ JelenaBezbradicaLab retweeted
Dr Rebecca Coll@Rebecca_Coll·2 Sep 2025

Delighted to share that our study with @bioagelabs NLRP3 inhibitors is now online @JExpMed ! Together with @Geyer_lab @benedicte_py and @Innate_immuno we characterise BAL-0028 and BAL-0598. Excited to see the new NLRP3 biology they will reveal!

#NLRP3 is a target for anti-inflammatory therapies & can be inhibited by the tool compound MCC950. Wilhelmsen, @Rebecca_Coll et al. characterize new small-molecule inhibitors, BAL-0028 & BAL-0598, that have a distinct mechanism of action & binding site. hubs.la/Q03GtbGx0

Post attachment